You have 9 free searches left this month | for more free features.

Carcinoma, Signet Ring Cell

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastric Cancer, Signet Ring Cell Carcinoma Trial in Hangzhou (Without any intervention)

Active, not recruiting
  • Gastric Cancer
  • Signet Ring Cell Carcinoma
  • Without any intervention
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Aug 2, 2023

Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo

Not yet recruiting
  • Colorectal Adenocarcinoma
  • +2 more
  • Trondheim, Trondelag, Norway
  • +2 more
Aug 15, 2022

Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Houston (drug,

Terminated
  • Rectal Mucinous Adenocarcinoma
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 21, 2022

Adenoid Cystic Skin Carcinoma, Adnexal Carcinoma, Anaplastic Large Cell Lymphoma, ALK-Negative Trial in United States

Recruiting
  • Adenoid Cystic Skin Carcinoma
  • +38 more
  • Biopsy
  • +6 more
  • Los Angeles, California
  • +35 more
Jan 31, 2023

Signet Ring Cell Gastric Adenocarcinoma Trial in Lille cedex (peri-operative chemo, Surgery first)

Recruiting
  • Signet Ring Cell Gastric Adenocarcinoma
  • peri-operative chemotherapy
  • Surgery first
  • Lille cedex, France
    General and digestive surgical department, Claude Huriez Hospita
Mar 25, 2021

Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adenocarcinoma of Unknown Primary Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +39 more
  • Chicago, Illinois
  • +1 more
May 7, 2020

Prostate Cancer, Prostate Adenocarcinoma, Prostatic Tumors Trial in Istanbul (Performing cognitive prostate biopsy with a

Recruiting
  • Prostate Cancer
  • +4 more
  • Performing cognitive prostate biopsy with a radiologist's guidance with map
  • Performing cognitive prostate biopsy without a radiologist's guidance with map
  • Istanbul, Turkey
    Marmara University, School of Medicine, Department of Urology
Jun 5, 2023

Poorly Differentiated Adenocarcinoma With Signet Ring Cells of

Completed
  • Gallbladder Cancer
  • laparoscopic whole-layer cholecystectomy
  • Ōita, Oita, Japan
    oita Red Cross hospital
Sep 24, 2022

Gastric Cancer, Gastro Esophageal Junctional Cancer, Cancer Trial (68Ga-FAPi-46)

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • (no location specified)
Jun 12, 2023

Gastric Adenocarcinoma Trial in France, Spain (HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) with oxaliplatin, Curative

Active, not recruiting
  • Gastric Adenocarcinoma
  • HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) with oxaliplatin
  • Curative gastrectomy
  • Amiens, France
  • +32 more
Jan 26, 2022

Proximal Gastric Adenocarcinoma, Reconstruction Trial in Shanghai (Double tract reconstruction, Gastric conduit reconstruction,

Recruiting
  • Proximal Gastric Adenocarcinoma
  • Reconstruction
  • Double tract reconstruction
  • +2 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital Fudan University
Sep 13, 2022

Fibroblast Activation Protein Inhibitor PET/CT Imaging in

Recruiting
  • Gastrointestinal Cancer
  • Fibroblast activation protein inhibitor PET/CT imaging
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 14, 2022

Rectal Mucinous Adenocarcinoma, Rectal Signet Ring Cell Adenocarcinoma, Recurrent Rectal Carcinoma Trial in Boston

Completed
  • Rectal Mucinous Adenocarcinoma
  • +10 more
  • Radiotherapy
  • +4 more
  • Boston, Massachusetts
    Eastern Cooperative Oncology Group
Dec 3, 2018

Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Tumor Trial in Wuhan (68Ga-FAPI, PET/CT)

Recruiting
  • Fibroblast Activation Protein Inhibitor
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Aug 27, 2021

Squamous Cell Carcinoma of Oral Cavity, Pharynx Carcinoma, Larynx Carcinoma Trial in Gliwice (Chemotherapy

Recruiting
  • Squamous Cell Carcinoma of Oral Cavity
  • +3 more
  • Chemotherapy (carboplatin+paclitaxel) with concomitant low dose ionizing radiotherapy
  • Gliwice, Silesia, Poland
    The Maria Sklodowska-Curie National Research Institute of Oncolo
Aug 7, 2023

Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

Recruiting
  • Renal Cell Carcinoma
  • 68Ga-NY104 PET/CT
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 5, 2023

Squamous Cell Carcinoma of Head and Neck, Basal Cell Carcinoma of Skin Trial in Vandœuvre-lès-Nancy (microscopy confocal

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Basal Cell Carcinoma of Skin
  • microscopy confocal (Histolog Scanner)
  • Vandœuvre-lès-Nancy, France
    Gilles Dolivet
Jul 7, 2023

The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC Trial in Hanzhou (Cadonilimab Combined Albumin-paclitaxel,

Recruiting
  • The Efficacy and Safety of Therapy Efficacy for Locally Advanced ESCC
  • Cadonilimab Combined Albumin-paclitaxel, Cisplatin and Fluorouracil
  • Hanzhou, Zhejiang, China
    Lulu Liu
Jul 14, 2023

Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)

Not yet recruiting
  • Squamous Cell Carcinoma of the Skin
  • Carrilizumab with albumin-binding paclitaxel
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
May 23, 2023

Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • 68Ga-NY104 PET/CT
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 18, 2023

Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • 68Ga-NY104 PET/CT
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 18, 2023

Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Head and Neck Squamous Cell Carcinoma
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 25, 2023

Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
  • (no location specified)
Mar 17, 2023

Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

Recruiting
  • Metastatic Esophageal Squamous Cell Carcinoma
  • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors(Sintilimab)
  • Qingdao, Shandong, China
  • +1 more
Nov 13, 2023

Urologic Cancer Trial in Taipei

Recruiting
  • Urologic Cancer
    • Taipei, Taiwan
      Yu wei-lan
    Feb 2, 2023